AmorChem invests in a new university gene therapy project

AmorChem has made an investment in a university project that will focus on a new gene therapy to help patients with retinal degeneration.

24 February 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles